Product image of Norepinephrine Basi (Norepinephrine) supplied by GNH India

Norepinephrine Basi

Active Ingredient:
Norepinephrine
Origin:
EU

Norepinephrine Basi (Norepinephrine)

Norepinephrine, the active ingredient in Norepinephrine Basi, is an adrenergic agonist presented as an intravenous formulation for intravenous use. It raises blood pressure in patients experiencing acute hypotension, including those in septic shock, and acts rapidly to increase vascular tone and support organ perfusion in critical care settings.

GNH India supplies Norepinephrine Basi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Laboratórios Basi – Indústria Farmacêutica, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Norepinephrine is used as a potent vasopressor to manage critical hypotensive states.

  • Hypotension: restores arterial pressure in patients with acute low blood pressure.
  • Septic shock: improves hemodynamic stability in septic shock by increasing systemic vascular resistance.
  • Cardiogenic shock: helps maintain perfusion when cardiac output is insufficient.

How It Works

  • Norepinephrine binds to and activates primarily alpha‑1 adrenergic receptors on vascular smooth muscle, causing vasoconstriction and an increase in systemic vascular resistance. It also stimulates beta‑1 receptors in the heart, modestly enhancing cardiac contractility and heart rate, which together raise mean arterial pressure and improve tissue perfusion in shock states.

Side Effects

Norepinephrine infusion can be associated with a range of adverse reactions.

Common Side Effects

  • Headache: mild to moderate pain often related to rapid blood pressure rise.
  • Tachycardia: increased heart rate due to beta‑1 stimulation.
  • Peripheral ischemia: reduced blood flow to extremities causing coldness or discoloration.
  • Extravasation injury: local tissue damage if the drug leaks from the vein.
  • Anxiety: feelings of nervousness or restlessness.
  • Hypertension: excessive rise in blood pressure.

Serious or Rare Side Effects

  • Severe hypertension: dangerously high blood pressure requiring immediate intervention.
  • Myocardial ischemia: reduced heart muscle oxygenation leading to chest pain or infarction.
  • Cardiac arrhythmias: potentially life‑threatening irregular heart rhythms.
  • Tissue necrosis: irreversible damage at the infusion site if extravasation occurs.
  • Pulmonary edema: fluid accumulation in the lungs due to increased afterload.

Precautions & Warnings

Norepinephrine requires careful monitoring and specific safety measures.

  • Monitor blood pressure: adjust infusion to maintain target MAP.
  • Assess cardiac function: watch for tachyarrhythmias and myocardial strain.
  • Avoid extravasation: ensure secure intravenous access and inspect site regularly.
  • Use cautiously in peripheral vascular disease: risk of ischemic complications.
  • Adjust dose in patients with renal or hepatic impairment: altered clearance may affect response.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Norepinephrine can interact with several drug classes, influencing its pressor effect.

Major Interactions (Avoid)

  • MAO inhibitors: risk of hypertensive crisis.
  • Tricyclic antidepressants: additive pressor effect may cause severe hypertension.
  • Beta‑blockers: may blunt expected tachycardia response.

Moderate Interactions (Monitor Closely)

  • Vasodilators (e.g., nitroglycerin): may require higher norepinephrine doses.
  • Calcium channel blockers: can affect vascular tone and response.
  • ACE inhibitors: may influence overall blood pressure control.

Frequently Asked Questions

Norepinephrine Basi is an injectable vasopressor indicated for the rapid correction of severe hypotension, including that which occurs in septic shock and cardiogenic shock. It is used in intensive‑care settings to restore adequate arterial pressure and maintain organ perfusion when conventional fluid therapy is insufficient.

Norepinephrine acts by stimulating alpha‑1 adrenergic receptors on vascular smooth muscle, causing potent vasoconstriction and an increase in systemic vascular resistance. It also engages beta‑1 receptors in the heart, modestly raising heart rate and contractility, together elevating mean arterial pressure to improve tissue perfusion.

The dosing regimen for Norepinephrine Basi is individualized. A qualified prescriber determines the infusion rate based on the patient’s blood pressure, cardiac output, and clinical response, typically starting with a low dose and titrating to achieve the desired hemodynamic target.

The pregnancy and lactation safety categories for norepinephrine are not well established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by the treating physician in consultation with obstetric specialists.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and necessary import documentation.

Compared with dopamine, norepinephrine provides a more predictable increase in vascular tone with less tachyarrhythmia risk. Phenylephrine offers pure alpha‑1 activity but lacks the modest beta‑1 effect of norepinephrine, which can be advantageous for supporting cardiac output in shock states.

Norepinephrine Basi should be stored at 2‑8 °C, protected from light, and kept in its original sealed container. Do not freeze or shake the solution. Before use, allow the product to reach room temperature if required, and inspect for any particulate matter or discoloration.

The drug is given as an intravenous infusion, typically through a central venous catheter or a well‑secured peripheral line. The infusion is prepared in a compatible diluent and administered using an infusion pump, with continuous blood pressure monitoring to guide dose adjustments.

Serious adverse events include severe hypertension, myocardial ischemia, life‑threatening cardiac arrhythmias, and tissue necrosis at the infusion site if extravasation occurs. Prompt recognition and immediate management of these complications are essential to minimize patient harm.

Patients with known hypersensitivity to norepinephrine or any component of the formulation should avoid its use. Caution is also advised in individuals with severe peripheral vascular disease, uncontrolled arrhythmias, or those receiving MAO inhibitors, as the risk of adverse cardiovascular events is heightened.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Norepinephrine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT